
    
      This is an extension study of a randomized controlled trial that will be conducted at the
      same 5 clinical sites as the primary study - All subjects who participated in the original
      randomization and did not withdraw from the study are eligible for the extension study
      including those with a history of secondary treatment following PACT RCT study participation.
    
  